Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

COMPLICATIONS AFTER HEAVY SILICONE OIL TAMPONADE IN COMPLICATED RETINAL DETACHMENT

Duan, Anli MD; She, Haicheng MD; Qi, Yue MD

doi: 10.1097/IAE.0b013e3181eef2fd
Original Study
Buy

Purpose: To observe the complications after heavy silicone oil (HSO) tamponade in complicated retinal detachment.

Methods: Thirty-three eyes of 33 patients with complicated retinal detachment were included in this retrospective study. Vitrectomy and HSO tamponade were performed in all patients. Other surgical procedures were performed as necessary. The main outcome measures included retinal reattachment, visual acuity, intraocular pressure, intraocular inflammation, lens opacity, and HSO emulsification.

Results: The patients were followed up for 3 months to 24 months (average, 8.1 ± 5.3 months). Retinal reattachment was achieved in 29 eyes (87.9%) with a first surgery and in 33 eyes (100%) with a second surgery. In all 33 eyes, HSO had been removed and the visual acuity was improved. Short-term (within 2 weeks after operations) complications included temporarily increased intraocular pressure and mild inflammation in the anterior chamber. Major long-term complications included cataract (100%) and HSO emulsification (42.4%). Other long-term complications included ocular hypertension (12.1%), retinal detachment and proliferative vitreoretinopathy (12.1%), and low intraocular pressure (9.1%).

Conclusion: Heavy silicone oil tamponade is safe and effective to treat complicated retinal detachment. The most common complications are cataract and HSO emulsification.

To study the complications of heavy silicone oil tamponade, a retrospective study of 33 patients with complicated retinal detachment was conducted. Vitrectomy and heavy silicone oil tamponade were performed in all patients. Heavy silicone oil tamponade was safe and effective to treat complicated retinal detachment. The most common complications were cataract and heavy silicone oil emulsification.

From the Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Lab, Beijing, China.

A. Duan and H. She have contributed equally to this article.

The authors have no proprietary interest to disclose.

Reprint requests: Anli Duan, MD, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Lab, 1, Dongjiaominxiang Street, Beijing 100730, China; e-mail: duananli@163.com

© The Ophthalmic Communications Society, Inc.